Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CT-P27 in an Influenza Challenge Model
NCT02071914Phase 2Completed
- Sponsor
- Celltrion
- Start
- Feb 2014
- Primary completion
- May 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of CT-P27 in Influenza A (IAV), sponsored by Celltrion. Started Feb 2014; status: completed.
02
Drugs
CT-P27
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT02071914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071914.